| Literature DB >> 29313213 |
P Garg1, R Aziz2, T Al Musa2, D P Ripley2, P Haaf2, J R J Foley2, P P Swoboda2, G J Fent2, L E Dobson2, J P Greenwood2, S Plein2.
Abstract
AIMS: Myocardial perfusion imaging during hyperaemic stress is commonly used to detect coronary artery disease. The aim of this study was to investigate the relationship between left ventricular global longitudinal strain (GLS), strain rate (GLSR), myocardial early (E') and late diastolic velocities (A') with adenosine stress first-pass perfusion cardiovascular magnetic resonance (CMR) imaging. METHODS ANDEntities:
Keywords: Adenosine; Cardiovascular magnetic resonance; Coronary artery disease; Left ventricular function; Perfusion imaging
Year: 2018 PMID: 29313213 PMCID: PMC5783894 DOI: 10.1007/s12471-017-1071-3
Source DB: PubMed Journal: Neth Heart J ISSN: 1568-5888 Impact factor: 2.380
Fig. 1Illustration demonstrating how fibre orientation of the left ventricle corresponds to perfusion defect gradient (high in sub-endocardium and lower in epicardium)
Fig. 2Two case examples: Case 1 (a–d). The top row shows CMR images of a 63-year-old female who presented with a history of chest pain. Panel a illustrates endo/epi contours on 4‑chamber cine acquisition at peak stress. Panel b demonstrates the derived myocardial feature tracking and computed systolic GLS at peak stress. Panel c shows the corresponding stress perfusion image at the time of peak myocardial contrast enhancement, showing no inducible perfusion defects. Panel d shows that there is no infarction on late gadolinium enhancement (LGE) imaging. Case 2 (e–h). The bottom row shows CMR images of a 59-year-old male who presented with a history of chest pain. This is a case with a perfusion defect in mid-ventricular septum (orange arrows in panel g) on first-pass perfusion with no evidence of previous myocardial infarction on LGE imaging (Panel h). Notably, the peak stress GLS was significantly lower in this case. (CMR cardiovascular magnetic resonance, GLS global longitudinal strain)
Study demographics and baseline CMR parameters
| Characteristics | All patients | Perfusion defect | No perfusion defect | |
|---|---|---|---|---|
|
| ( | ( | ( | |
| Age (years) | 64 ± 12 | 64 ± 12 | 63 ± 13 | 0.53 |
| Gender (male/female) | 31/13 | 16/6 | 15/7 | 0.75 |
| Current smoker (no. [%]) | 13 (30) | 7 (16) | 6 (14) | 0.75 |
| Hypertension (no. [%]) | 13 (30) | 7 (16) | 6 (14) | 0.75 |
| Diabetes Mellitus (no. [%]) | 12 (27) | 6 (14) | 7 (16) | 0.45 |
| Dyslipidaemia (no. [%]) | 7 (16) | 3 (7) | 4 (9) | 0.69 |
| Myocardial Infarction (no. [%]) | 17 (39) | 10 (23) | 6 (14) | 0.22 |
| CABG (no. [%]) | 6 (14) | 4 (9) | 1 (2) | 0.13 |
| Abnormal ECG (no. [%]) | 13 (30) | 8 (18) | 5 (11) | 0.33 |
|
| ||||
| LV EDV, (ml/m2) | 143 ± 45 | 151 ± 46 | 133 ± 43 | 0.19 |
| LV ESV, (ml/m2) | 55 ± 32 | 63 ± 39 | 45 ± 21 | 0.06 |
| LV SV, (ml/m2) | 86 ± 29 | 87.6 ± 18 | 84.4 ± 37 | 0.72 |
| LV EF, (%) | 64 ± 13 | 61 ± 13 | 67 ± 12 | 0.07 |
| LV Mass (grams) | 111 ± 35 | 112 ± 26 | 109 ± 43 | 0.76 |
| Presence of Infarction (%) | 25 (57%) | 15 (34%) | 10 (23%) | 0.13 |
|
| ||||
| GLS (%) | −18 ± 4 | −16.9 ± 3.7 | −19.6 ± 3.4 | 0.02 |
| GLSR (s−1) | −98 ± 11 | −86 ± 22 | −109 ± 38 | 0.02 |
| E’ (s−1) | 80 ± 39 | 69 ± 31 | 93 ± 38 | 0.04 |
| A’ (s−1) | 80 ± 29 | 74.5 ± 25 | 86.7 ± 33 | 0.18 |
|
| ||||
| GLS (%) | −19 ± 4 | −16.5 ± 4 | −21.2 ± 3.1 | <0.001 |
| GLSR (s−1) | −104 ± 54 | −98 ± 45 | −112 ± 60 | 0.36 |
| E’ (s−1) | 97 ± 41 | 90 ± 50 | 106 ± 32 | 0.21 |
| A’ (s−1) | 93 ± 50 | 88 ± 43 | 113 ± 81 | 0.20 |
Data are presented as mean (standard deviation) or as numbers (%), unless otherwise indicated. P-value <0.05 was taken as significant
A’ myocardial late diastolic velocity, CABG coronary artery bypass grafting, CMR cardiovascular magnetic resonance, E’ myocardial early diastolic velocity, ECG electrocardiogram, EDV end-diastolic volume, EF ejection fraction, ESV end-systolic volume, GLS global longitudinal strain, GLSR global longitudinal strain rate, LV left ventricular, SV stroke volume
Myocardial deformation parameters in the two patient groups
| Presence of MI | Strain parameters | With perfusion defect | Without perfusion defect | ||
|---|---|---|---|---|---|
|
| LGE− | GLS (%) | −19 ± 5 | −20 ± 3 | 0.59 |
| GLSR (s−1) | −101 ± 19 | −119 ± 53 | 0.41 | ||
| E’ (s−1) | 94 ± 32 | 102 ± 52 | 0.69 | ||
| A’ (s−1) | 93 ± 15 | 97 ± 36 | 0.75 | ||
| LGE+ | GLS (%) | −16 ± 3 | −19 ± 4 | 0.04 | |
| GLSR (s−1) | −78 ± 20 | −99 ± 13 | 0.01 | ||
| E’ (s−1) | 56 ± 21 | 81 ± 30 | 0.02 | ||
| A’ (s−1) | 66 ± 24 | 74 ± 25 | 0.45 | ||
|
| LGE− | GLS (%) | −18 ± 4 | −22 ± 3 | 0.02 |
| GLSR (s−1) | −136 ± 55 | −102 ± 77 | 0.32 | ||
| E’ (s−1) | 128 ± 62 | 111 ± 24 | 0.39 | ||
| A’ (s−1) | 113 ± 46 | 113 ± 69 | 0.99 | ||
| LGE+ | GLS (%) | −16 ± 4 | −20 ± 3 | 0.01 | |
| GLSR (s−1) | −80 ± 27 | −125 ± 27 | <0.001 | ||
| E’ (s−1) | 72 ± 32 | 101 ± 40 | 0.06 | ||
| A’ (s−1) | 76 ± 36 | 114 ± 97 | 0.18 |
Data are presented as mean (standard deviation) or as numbers (%), unless otherwise indicated. P-value <0.05 was taken as significant
A’ myocardial late diastolic velocity, E’ myocardial early diastolic velocity, GLS global longitudinal strain, GLSR global longitudinal strain rate, LGE+ late gadolinium enhancement present, LGE− late gadolinium enhancement absent, MI myocardial infarction
Fig. 3Multiple comparison bars of rest (Panel a) and stress (Panel b) global longitudinal function strain in patients with/without myocardial infarction and perfusion defect (whiskers: standard deviations; SD)
C-statistics for myocardial longitudinal parameters at rest and stress CMR
| Youden | Sensitivity (%) | Specificity (%) | AUC | 95% CI | |||
|---|---|---|---|---|---|---|---|
|
| GLS (%) | >−18.55 | 77.27 | 68.18 | 0.72 | 0.56–0.87 | 0.006 |
| GLSR (s−1) | >−91.09 | 68.18 | 72.73 | 0.75 | 0.60–0.89 | 0.0008 | |
| E’ (s−1) | ≤84.53 | 86.36 | 54.55 | 0.70 | 0.54–0.86 | 0.01 | |
| A’ (s−1) | ≤108.86 | 100 | 32 | 0.59 | 0.42–0.77 | 0.28 | |
|
| GLS (%) | >−19.80 | 77.3 | 72.7 | 0.82 | 0.70–0.94 | <0.001 |
| GLSR (s−1) | >−99.7 | 63.6 | 86.4 | 0.74 | 0.58–0.89 | 0.003 | |
| E’ (s−1) | ≤81.65 | 50 | 82 | 0.67 | 0.50–0.83 | 0.04 | |
| A’ (s−1) | ≤58.65 | 36.36 | 86.36 | 0.58 | 0.41–0.76 | 0.34 | |
|
| 28% | 96 | 68 | 0.87 | 0.76–0.97 | <0.0001 | |
Data as presented as mean (standard deviation) or as numbers (%), unless otherwise indicated. P-value <0.05 was taken as significant
A’ myocardial late diastolic velocity, AUC area under the curve, CI confidence interval, CMR cardiovascular magnetic resonance, E’ myocardial early diastolic velocity, GLS global longitudinal strain, GLSR global longitudinal strain rate
aModel comprising of strain parameters associated to the presence of perfusion defect in univariate analysis: rest GLS, rest GLSR, rest E’ and stress GLS
Fig. 4Receiver operating characteristic (ROC) curves of different strain models to predict the presence of myocardial perfusion defect: Resting global longitudinal strain (GLS) model (I), stress GLS (II) and strain model versus rest GLS (III)